E-LIB Suche - Ergebnisse für: Ignacio Garrido-Laguna

1

Results of a Randomized, Double-Blind, Placebo-Controlled, ..:

Gardner, Faithlore P. ; Wainberg, Zev A. ; Fountzilas, Christos...
Cancers. 16 (2024) 7 - p. 1323 , 2024

Link: https://doi.org/10.3390/..

2

NALIRIFOX for metastatic pancreatic adenocarcinoma: hope or..:

Nevala-Plagemann, Christopher ; Garrido-Laguna, Ignacio
Nature Reviews Clinical Oncology. , 2024

Link: https://doi.org/10.1038/..

3

Cabozantinib plus atezolizumab in previously untreated adva..:

Li, Daneng ; Loriot, Yohann ; Burgoyne, Adam M....
eClinicalMedicine. 67 (2024) - p. 102376 , 2024

Link: https://doi.org/10.1016/..

4

Real-world pan-cancer landscape of frameshift mutations and..:

Florou, Vaia ; Floudas, Charalampos S ; Maoz, Asaf...
Journal for ImmunoTherapy of Cancer. 11 (2023) 8 - p. e007440 , 2023

Link: https://doi.org/10.1136/..

5

Phase I/Ib, open-label, multicenter, dose-escalation study ..:

Bauer, Todd M ; Santoro, Armando ; Lin, Chia-Chi...
Journal for ImmunoTherapy of Cancer. 11 (2023) 11 - p. e007353 , 2023

Link: https://doi.org/10.1136/..

6

Phase 1 study of GSK3368715, a type I PRMT inhibitor, in pa..:

El-Khoueiry, Anthony B. ; Clarke, James ; Neff, Tobias...
British Journal of Cancer. 129 (2023) 2 - p. 309-317 , 2023

Link: https://doi.org/10.1038/..

7

Feasibility and acceptability of an mHealth, home-based exe..:

Moraitis, Ann Marie ; Rose, Nathan B. ; Johnson, Austin F....
PLOS ONE. 18 (2023) 6 - p. e0287152 , 2023

Link: https://doi.org/10.1371/..

8

Treatment outcomes in recurrent versus de novo metastatic p..:

Miotke, Laura ; Nevala-Plagemann, Christopher ; Ying, Jian...
BMC Cancer. 22 (2022) 1 - p. , 2022

Link: https://doi.org/10.1186/..

9

Epacadostat Plus Pembrolizumab and Chemotherapy for Advance..:

Powderly, John D ; Klempner, Samuel J ; Naing, Aung...
The Oncologist. 27 (2022) 11 - p. 905-e848 , 2022

Link: https://doi.org/10.1093/..

10

Clinical Development of Anti-TIGIT Antibodies for Immunothe..:

Florou, Vaia ; Garrido-Laguna, Ignacio
Current Oncology Reports. 24 (2022) 9 - p. 1107-1112 , 2022

Link: https://doi.org/10.1007/..

11

The Implications of Treatment Delays in Adjuvant Therapy fo..:

Parsons, Matthew ; Lloyd, Shane ; Johnson, Skyler...
Journal of Gastrointestinal Cancer. 54 (2022) 2 - p. 492-500 , 2022

Link: https://doi.org/10.1007/..

12

A Phase 1 Dose-Escalation Study of PF-06671008, a Bispecifi..:

Harding, James J. ; Garrido-Laguna, Ignacio ; Chen, Xiaoying...
Frontiers in Immunology. 13 (2022) - p. , 2022

Link: https://doi.org/10.3389/..

13

Exploring the safety, effect on the tumor microenvironment,..:

Naing, Aung ; Powderly, John D ; Nemunaitis, John J...
Journal for ImmunoTherapy of Cancer. 10 (2022) 3 - p. e004223 , 2022

Link: https://doi.org/10.1136/..

14

A Preclinical and Phase Ib Study of Palbociclib plus Nab-Pa..:

Hidalgo, Manuel ; Garcia-Carbonero, Rocio ; Lim, Kian-Huat...
Cancer Research Communications. 2 (2022) 11 - p. 1326-1333 , 2022

Link: https://doi.org/10.1158/..

15

A Phase I, First-in-Human Study of GSK2849330, an Anti-HER3..:

Gan, Hui K. ; Millward, Michael ; Jalving, Mathilde...
The Oncologist. 26 (2021) 10 - p. e1844-e1853 , 2021

Link: https://doi.org/10.1002/..